Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.
OBJECTIVE: To investigate the regulation of expression of the angiogenic cytokine vascular endothelial growth factor (VEGF) in rheumatoid arthritis (RA), in order to determine whether new blood vessel formation could be a potential therapeutic target in RA. METHODS: Dissociated RA synovial membrane...
Κύριοι συγγραφείς: | Paleolog, E, Young, S, Stark, A, McCloskey, R, Feldmann, M, Maini, R |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
1998
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis.
ανά: Taylor, P, κ.ά.
Έκδοση: (2000) -
Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.
ανά: Feldmann, M, κ.ά.
Έκδοση: (1997) -
Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis.
ανά: Paleolog, E, κ.ά.
Έκδοση: (1996) -
Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis.
ανά: Feldmann, M, κ.ά.
Έκδοση: (1997) -
Contrasting effects of interferon gamma and interleukin 4 on responses of human vascular endothelial cells to tumour necrosis factor alpha.
ανά: Paleolog, E, κ.ά.
Έκδοση: (1992)